Showing results (251-260 of 317) with videos related to

Sort By:
Pageof 32
Archives of Pathology & Laboratory Medicine|August 21, 2019
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431Kelley J Mast, Jeffrey W Taub, Todd A Alonzo, et al.
Cytometry. Part B, Clinical Cytometry|July 12, 2019
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupLaura M Pardo, Andrew P Voigt, Todd A Alonzo, et al.
Genetics and Molecular Research : GMR|December 5, 2013
Association of the tumor necrosis factor-alpha -308G>A polymorphism with breast cancer in Mexican womenL Gómez Flores-Ramos, A Escoto-De Dios, A M Puebla-Pérez, et al.
Frontiers in Cardiovascular Medicine|July 1, 2024
Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group reportKasey J Leger, Michael J Absalon, Biniyam G Demissei, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusionNathaniel J Buteyn, Connor G Burke, Vincent J Sartori, et al.
Cancer|November 20, 2023
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemiaJenny Ruiz, Yimei Li, Lusha Cao, et al.
Leukemia & Lymphoma|January 5, 2016
A comparison of discharge strategies after chemotherapy completion in pediatric patients with acute myeloid leukemia: a report from the Children's Oncology GroupTamara P Miller, Kelly D Getz, Marko Kavcic, et al.
Blood|April 9, 2017
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trialJeffrey W Taub, Jason N Berman, Johann K Hitzler, et al.
Blood Advances|October 20, 2020
Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 reportLisa Eidenschink Brodersen, Robert B Gerbing, M Laura Pardo, et al.
Pediatric Blood & Cancer|October 1, 2021
Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology GroupCaitlin W Elgarten, Andrew C Wood, Yimei Li, et al.
Pageof 32